FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Steven Cohen

Research Profile

Disorders

Procedures

Chemicals & Drugs

Anatomy

Circulating Neoplastic Cells

Concepts & Ideas

Co-author Network

Publications

TOP 3
Barbara Burtness; Erica A Golemis; SHANTHI MARUR; Ranee Mehra; Julie E Bauman; Steven J Cohen
Comment on "epidermal growth factor receptor is essential for toll-like receptor 3 signaling".
Tracy Klayton; Jonathan Cheng; Steven J Cohen; Lanea Keller; Tianyu Li; Neal J Meropol; Walter Scott; Meng Xu-Welliver; Jian Q Yu; Andre Konski
The role of qualitative and quantitative analysis of F18-FDG positron emission tomography in predicting pathologic response following chemoradiotherapy in patients with esophageal carcinoma.
Efrat Dotan; James Lee; Neal J Meropol; David Mintzer; Karen Ruth; Judi Sylvester; Holly Tuttle; Fang Zhu; Barbara Burtness; Crystal S Denlinger; Steven J Cohen
A phase II study of capecitabine, oxaliplatin, and cetuximab with or without bevacizumab as frontline therapy for metastatic colorectal cancer. A Fox Chase extramural research study.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Steven Cohen (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Barbara Burtness; Erica A Golemis; SHANTHI MARUR; Ranee Mehra; Julie E Bauman; Steven J Cohen
Comment on "epidermal growth factor receptor is essential for toll-like receptor 3 signaling".
Science signaling 2012;5(254):lc5.
2012: Tracy Klayton; Jonathan Cheng; Steven J Cohen; Lanea Keller; Tianyu Li; Neal J Meropol; Walter Scott; Meng Xu-Welliver; Jian Q Yu; Andre Konski
The role of qualitative and quantitative analysis of F18-FDG positron emission tomography in predicting pathologic response following chemoradiotherapy in patients with esophageal carcinoma.
Journal of gastrointestinal cancer 2012;43(4):612-8.
2012: Efrat Dotan; James Lee; Neal J Meropol; David Mintzer; Karen Ruth; Judi Sylvester; Holly Tuttle; Fang Zhu; Barbara Burtness; Crystal S Denlinger; Steven J Cohen
A phase II study of capecitabine, oxaliplatin, and cetuximab with or without bevacizumab as frontline therapy for metastatic colorectal cancer. A Fox Chase extramural research study.
Journal of gastrointestinal cancer 2012;43(4):562-9.
2012: Andre Konski; Tianyu Li; Alan Maurer; Neal J Meropol; Walter Scott; Jeffrey Tokar; Jian Q Yu; Jonathan D Cheng; Michael Christensen; Steven J Cohen; Kevin Crawford; Oleh Haluszka; Gary M Freedman
Symptomatic cardiac toxicity is predicted by dosimetric and patient factors rather than changes in 18F-FDG PET determination of myocardial activity after chemoradiotherapy for esophageal cancer.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2012;104(1):72-7.
2012: E Dotan; Andrew K Godwin; Erica A Golemis; N J Meropol; F Zambito; F Zhu; Igor Astsaturov; Betsy Bove; Kathy Qi Cai; Steven J Cohen
Relationship of increased aurora kinase A gene copy number, prognosis and response to chemotherapy in patients with metastatic colorectal cancer.
British journal of cancer 2012;106(4):748-55.
2011: Yun Shin Chun; Steven J Cohen; Harry S Cooper; Crystal S Denlinger; Michael J Hall; Igor Astsaturov; Barbara Burtness; Andre Konski; John P Hoffman
Significance of pathologic response to preoperative therapy in pancreatic cancer.
Annals of surgical oncology 2011;18(13):3601-7.
2011: Sameer Gupta; Paul F Engstrom; Steven J Cohen
Emerging therapies for advanced gastroenteropancreatic neuroendocrine tumors.
Clinical colorectal cancer 2011;10(4):298-309.
2011: Efrat Dotan; Steven J Cohen
Challenges in the management of stage II colon cancer.
Seminars in oncology 2011;38(4):511-20.
2011: Navesh Sharma; Joshua S Silverman; Jian Q Yu; Tianyu Li; Neal J Meropol; Walter Scott; Jonathan Cheng; Steven J Cohen; Gary M Freedman; Oleh Haluszka; Andre Konski
Decreased Posttreatment SUV on PET Scan Is Associated With Improved Local Control in Medically Inoperable Esophageal Cancer.
Gastrointestinal cancer research : GCR 2011;4(3):84-9.
2011: Igor A Astsaturov; Neal J Meropol; R Katherine Alpaugh; Barbara Burtness; Jonathan D Cheng; Sue McLaughlin; André Rogatko; Zhiheng Xu; James C Watson; Louis M Weiner; Steven J Cohen
Phase II and coagulation cascade biomarker study of bevacizumab with or without docetaxel in patients with previously treated metastatic pancreatic adenocarcinoma.
American journal of clinical oncology 2011;34(1):70-5.
2010: Yun Shin Chun; Barton N Milestone; James C Watson; Steven J Cohen; Barbara Burtness; Paul F Engstrom; Oleh Haluszka; Jeffrey L Tokar; Michael J Hall; Crystal S Denlinger; Igor Astsaturov; John P Hoffman
Defining venous involvement in borderline resectable pancreatic cancer.
Annals of surgical oncology 2010;17(11):2832-8.
2010: Steven J Cohen; Mark M Zalupski; Manuel R Modiano; Paul Conkling; Yehuda Z Patt; Peg Davis; Robert T Dorr; Michelle L Boytim; Evan M Hersh
A phase I study of imexon plus gemcitabine as first-line therapy for advanced pancreatic cancer.
Cancer chemotherapy and pharmacology 2010;66(2):287-94.
2010: Benjamin P Negin; Steven J Cohen
Circulating tumor cells in colorectal cancer: past, present, and future challenges.
Current treatment options in oncology 2010;11(1-2):1-13.
2009: Steven J Cohen; Cornelis J A Punt; N Iannotti; B H Saidman; K D Sabbath; N Y Gabrail; Joel Picus; M A Morse; E Mitchell; M Craig Miller; G V Doyle; H Tissing; Leon W M M Terstappen; Neal J Meropol
Prognostic significance of circulating tumor cells in patients with metastatic colorectal cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2009;20(7):1223-9.
2009: Donald A Podoloff; Douglas W Ball; Edgar Ben-Josef; Al B Benson; Steven J Cohen; R Edward Coleman; Dominique Delbeke; Maria Ho; David H Ilson; Gregory P Kalemkerian; Richard J Lee; Jay S Loeffler; Homer A Macapinlac; Robert J Morgan; Barry Alan Siegel; Seema Singhal; Douglas S Tyler; Richard J Wong
NCCN task force: clinical utility of PET in a variety of tumor types.
Journal of the National Comprehensive Cancer Network : JNCCN 2009;7 Suppl 2():S1-26.
2009: Andre Konski; Tianyu Li; Elin R Sigurdson; Steven J Cohen; William Small; Stewart Spies; Jian Q Yu; Andrew Wahl; Steven Stryker; Neal J Meropol
Use of molecular imaging to predict clinical outcome in patients with rectal cancer after preoperative chemotherapy and radiation.
International journal of radiation oncology, biology, physics 2009;74(1):55-9.
2009: Eileen Ke; Bhavinkumar B Patel; Tiffany Liu; Xin-Ming Li; Oleh Haluszka; John P Hoffman; Hormoz Ehya; Nancy A Young; James C Watson; David S Weinberg; Minhhuyen T Nguyen; Steven J Cohen; Neal J Meropol; Samuel Litwin; Jeffrey L Tokar; Anthony T Yeung
Proteomic analyses of pancreatic cyst fluids.
Pancreas 2009;38(2):e33-42.
2009: Margot Roberts Sweed; Donna Edmonson; Steven J Cohen
Tumors of the esophagus, gastroesophageal junction, and stomach.
Seminars in oncology nursing 2009;25(1):61-75.
2008: Steven J Cohen; R Katherine Alpaugh; Irma Palazzo; Neal J Meropol; André Rogatko; Zhiheng Xu; John P Hoffman; Louis M Weiner; Jonathan D Cheng
Fibroblast activation protein and its relationship to clinical outcome in pancreatic adenocarcinoma.
Pancreas 2008;37(2):154-8.
2008: Steven J Cohen; Cornelis J A Punt; Nicholas Iannotti; Bruce H Saidman; Kert D Sabbath; Nashat Y Gabrail; Joel Picus; Michael Morse; Edith Mitchell; M Craig Miller; Gerald V Doyle; Henk Tissing; Leon W M M Terstappen; Neal J Meropol
Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(19):3213-21.
2008: Karyn B Stitzenberg; James C Watson; Andrew Roberts; Steven A Kagan; Steven J Cohen; Andre Konski; John P Hoffman
Survival after pancreatectomy with major arterial resection and reconstruction.
Annals of surgical oncology 2008;15(5):1399-406.
2008: Kimberly M Brown; Veeriah Siripurapu; Marson Davidson; Steven J Cohen; Andre Konski; James C Watson; Tiaynu Li; Vince Ciocca; Harry Cooper; John P Hoffman
Chemoradiation followed by chemotherapy before resection for borderline pancreatic adenocarcinoma.
American journal of surgery 2008;195(3):318-21.
2008: Steven J Cohen; Paul F Engstrom; Nancy L Lewis; Corey J Langer; Susan McLaughlin; Mary Beard; Louis M Weiner; Neal J Meropol
Phase I study of capecitabine and oxaliplatin in combination with the proteasome inhibitor bortezomib in patients with advanced solid tumors.
American journal of clinical oncology 2008;31(1):1-5.
2007: Kalyani Narra; Stefanie R Mullins; Hyung-Ok Lee; Brenda Strzemkowski-Brun; Kimberly Magalong; Victoria J Christiansen; Patrick A McKee; Brian Egleston; Steven J Cohen; Louis M Weiner; Neal J Meropol; Jonathan D Cheng
Phase II trial of single agent Val-boroPro (Talabostat) inhibiting Fibroblast Activation Protein in patients with metastatic colorectal cancer.
Cancer biology & therapy 2007;6(11):1691-9.
2007: Crystal S Denlinger; Steven J Cohen
Progress in the development of prognostic and predictive markers for gastrointestinal malignancies.
Current treatment options in oncology 2007;8(5):339-51.
2007: Margaret A O'Grady; Elena Gitelson; Ramona F Swaby; Lori J Goldstein; Elaine Sein; Patricia Keeley; Bonnie Miller; Tianyu Li; Alan Weinstein; Steven J Cohen
Development and implementation of a medical oncology quality improvement tool for a regional community oncology network: the Fox Chase Cancer Center Partners initiative.
Journal of the National Comprehensive Cancer Network : JNCCN 2007;5(9):875-82.
2007: Andre Konski; Jonathan D Cheng; Melvyn Goldberg; Tianyu Li; Alan Maurer; Jian Q Yu; Oleh Haluszka; Walter Scott; Neal J Meropol; Steven J Cohen; Gary Freedman; Louis M Weiner
Correlation of molecular response as measured by 18-FDG positron emission tomography with outcome after chemoradiotherapy in patients with esophageal carcinoma.
International journal of radiation oncology, biology, physics 2007;69(2):358-63.
2006: Steven J Cohen; Barbara Burtness
Novel targets in pancreatic cancer: focus on future paths to therapy.
Expert opinion on therapeutic targets 2006;10(5):771-5.
2006: Steven J Cohen; R Katherine Alpaugh; Steve Gross; S Mark O'Hara; Denis A Smirnov; Leon W M M Terstappen; W Jeffrey Allard; Maryann Bilbee; Jonathan D Cheng; John P Hoffman; Nancy L Lewis; Ann Pellegrino; André Rogatko; Elin R Sigurdson; Hao Wang; James C Watson; Louis M Weiner; Neal J Meropol
Isolation and characterization of circulating tumor cells in patients with metastatic colorectal cancer.
Clinical colorectal cancer 2006;6(2):125-32.
2005: Andre Konski; John Hoffman; Elin R Sigurdson; Oleh Haluszka; Paul F Engstrom; Jonathan D Cheng; Steven J Cohen; James C Watson; Debra Eisenberg; Eileen McGarrity; Gary Freedman; Neal J Meropol
Can molecular imaging predict response to preoperative chemoradiation in patients with rectal cancer? A Fox Chase Cancer Center prospective experience.
Seminars in oncology 2005;32(6 Suppl 9):S63-7.
2005: Steven J Cohen; Roger B Cohen; Neal J Meropol
Targeting signal transduction pathways in colorectal cancer--more than skin deep.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(23):5374-85.
2005: Steven J Cohen; Ralph Dobelbower; Stuart Lipsitz; Paul J Catalano; Benjamin Sischy; Thomas J Smith; Daniel G Haller
A randomized phase III study of radiotherapy alone or with 5-fluorouracil and mitomycin-C in patients with locally advanced adenocarcinoma of the pancreas: Eastern Cooperative Oncology Group study E8282.
International journal of radiation oncology, biology, physics 2005;62(5):1345-50.
2005: Mark L Sundermeyer; Neal J Meropol; André Rogatko; Hao Wang; Steven J Cohen
Changing patterns of bone and brain metastases in patients with colorectal cancer.
Clinical colorectal cancer 2005;5(2):108-13.
2005: Denis A Smirnov; Daniel R Zweitzig; Bradley W Foulk; M Craig Miller; Gerald V Doyle; Kenneth J Pienta; Neal J Meropol; Louis M Weiner; Steven J Cohen; Jose G Moreno; Mark C Connelly; Leon W M M Terstappen; S Mark O'Hara
Global gene expression profiling of circulating tumor cells.
Cancer research 2005;65(12):4993-7.
2004: Steven J Cohen; James Gallo; Nancy L Lewis; R Katherine Alpaugh; Louis Gentner; André Rogatko; Gwen Yeslow; Jessie Schol; Tom Verhaeghe; Peter Zannikos; Peter A Palmer; Louis M Weiner; Neal J Meropol
Phase I and pharmacokinetic study of the farnesyltransferase inhibitor R115777 in combination with irinotecan in patients with advanced cancer.
Cancer chemotherapy and pharmacology 2004;53(6):513-8.
2003: Steven J Cohen; Linus Ho; Sulabha Ranganathan; James L Abbruzzese; R Katherine Alpaugh; Mary Beard; Nancy L Lewis; Susan McLaughlin; André Rogatko; Juan Jose Perez-Ruixo; Amanda M Thistle; Tom Verhaeghe; Hao Wang; Louis M Weiner; John J Wright; Gary R Hudes; Neal J Meropol
Phase II and pharmacodynamic study of the farnesyltransferase inhibitor R115777 as initial therapy in patients with metastatic pancreatic adenocarcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(7):1301-6.
2002: Steven J Cohen; Cynthia G Leichman; Gwen Yeslow; Mary Beard; April Proefrock; Brian Roedig; Bharat Damle; Stephen P Letrent; Arthur P DeCillis; Neal J Meropol
Phase I and pharmacokinetic study of once daily oral administration of S-1 in patients with advanced cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(7):2116-22.
2002: Steven J Cohen; Neal J Meropol
Drug development in pancreatic cancer: finally, biology begets therapy.
International journal of gastrointestinal cancer 2002;32(2-3):91-106.
2000: Steven J Cohen; Wayne H Pinover; James C Watson; Neal J Meropol
Pancreatic cancer.
Current treatment options in oncology 2000;1(5):375-86.